[1]
|
Dimitradis, G., et al. (1983) Effects of long acting somatostatin analogue on post-prandial hyperglycemia in insulin-dependent diabetes mellitus. Metabolism 32, 987- 992. doi:10.1016/0026-0495(83)90140-3
|
[2]
|
Spinas, G.A., et al. (1985) .Reduced post-prandial hyperglycemia after subcutaneous injection of a somatostatin- analogue (SMS 201-995) in insulin dependent diabetes mellitus. Diabetes Care, 8, 429-435.
doi:10.2337/diacare.8.5.429
|
[3]
|
Rios, M.S., Navascues, I., Saban, J., Ordonez, A., Sevilla, F. and Del Pozo, E. (1986) Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas. The Journal of Clinical Endocrinology & Metabolism, 63, 1071-1074.
|
[4]
|
Grossman, L.D., Shumak, S.L., George, S.R., Singer, W. and Zinman, B. (1989) The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism, 68, 63-70. doi:10.1210/jcem-68-1-63
|
[5]
|
Ludwigsen, E., Stridsberg, M., Taylor, J.E., Cutler, M.D., Oberg, K., Janson, E.T. and Standler S. (2007) Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues. Regulatory Peptides, 138, 1-9. doi:10.1016/j.regpep.2006.07.006
|
[6]
|
Singh, V., Brenel, M.D., Zacharias, S., Mergler, S., Jahr, H., Wiedemnan, B., Bretzel, R.G., Plockinger, U., and Strowski, M.Z., (2007) Charecterization of soamtostatin receptor subtype-specific regulation of insulin and glucagon secretion: An in vitro study on isolated human pancreas. The Journal of Clinical Endocrinology & Metabolism, 92, 673-680. doi:10.1210/jc.2006-1578
|
[7]
|
Brazeau, P., Vale, W. and Burgus, R. (1973) Hypothalamic Polypeptide that Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone. Science, 179, 77-83. doi:10.1126/science.179.4068.77
|
[8]
|
Fery, F., Tappy, L., Schneiter, P., Daviere, J.E. and Balasse, O. (2005) Effect of Somatostatin on Duodenal Glucose Absorption in Man. The Journal of Clinical Endocrinology & Metabolism, 90, 4163-4169.
doi:10.1210/jc.2004-1766
|
[9]
|
Manjila, S., Wu, O.C., Khan, F.R., Khan, M.M., Arafah, B.M. and Setman, W.R. (2010) Pharmacological management of acromegaly: A current perspective. Neurosurgical Focus, 29, E14-24.
doi:10.3171/2010.7.FOCUS10168
|
[10]
|
Corleto, V.D. (2010) Somatostatin and the gastrointestinal tract. Current Opinion in Endocrinology, Diabetes & Obesity, 17, 63-68.
|